Uniphar acquires EPS
Uniphar has acquired 100% of the shares in the EPS Group, comprising of EP Endovascular AB and EPS Vascular AB, both registered in Sweden, and EPS Vascular Oy registered in Finland.
The EPS Group delivers sales, marketing and distribution services to medical device manufacturers in the therapeutic areas of interventional cardiology and vascular medicine across Sweden, Denmark, Norway, Finland, Iceland and the Baltics.
Uniphar is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access, and Supply Chain & Retail. With a workforce of more than 2,000, the Uniphar group is active in Ireland, the UK, the Benelux, the US and now the Nordics following the acquisition of the EPS Group.
Mannheimer Swartling acted as lead counsel in the transaction.
